Brain abscess in immunocompetent patients: recent findings

Purpose of review We conducted a systematic review of the literature to update findings on the epidemiology and the management of cerebral abscesses in immunocompetent patients. Recent findings Observational studies suggest that the overall prognosis has improved over the last decades but mortality rates remain high. Several parameters may contribute to a better prognosis, including the identification of common risk factors for brain abscess, the systematic use of brain MRI at diagnosis, the implementation of appropriate neurosurgical and microbiological techniques for diagnosis, the optimization of the antibacterial treatment based on epidemiology and pharmacokinetic/pharmacodynamic studies, and a long-term follow-up for detection of secondary complications. Outcome research on brain abscess is mainly based on observational studies. Randomized controlled trials have yet to be performed to identify clinically relevant interventions associated with improved patient-centered outcomes. Our review highlights the importance of a multidisciplinary approach to optimize brain abscess management both at the acute phase and in the long-term. Randomized controlled studies are urgently needed to identify interventions associated with improved outcomes.

Automated summary

This review provides an update on the epidemiology and management of cerebral abscesses in immunocompetent patients. Observational studies suggest an improvement in overall prognosis but high mortality rates remain. Various factors contribute to a better prognosis, including identification of risk factors, use of MRI for diagnosis, appropriate neurosurgical and microbiological techniques, optimized antibacterial treatment, and long-term follow-up for complications. Further randomized controlled trials are needed to identify interventions for improved outcomes.